Navigation Links
Baxter to Proceed With Recall of Remaining Heparin Sodium Vial Products
Date:2/28/2008

DEERFIELD, Ill., Feb. 28 /PRNewswire-FirstCall/ -- Baxter International Inc. announced today that the company is proceeding with the voluntary recall of all remaining lots and doses of its heparin sodium injection multi-dose, single-dose vials and HEP-LOCK heparin flush products.

The company initially recalled nine lots of heparin sodium injection multi-dose vials on January 17, 2008 as a precautionary measure due to a higher than usual number of reports of adverse patient reactions involving the product and suspended production earlier this month.

Given the widespread use of this blood thinner and the impact a product shortage would have on operating rooms, dialysis centers and other critical care areas, the FDA and Baxter concluded that removing additional lots and doses of Baxter's heparin from the market earlier would have created more risk to patients requiring heparin therapy than the increased potential for experiencing an adverse reaction. Accordingly, the FDA and Baxter decided not to recall all Baxter heparin vial products at that time. The FDA has now concluded that there is sufficient capacity on the part of other suppliers that Baxter's recall will not jeopardize access to this drug, and has told Baxter that the company can now proceed with recalling its remaining heparin sodium injection and heparin flush products.

Although the vast majority of the reports of adverse reactions have been associated with the multi-dose products, Baxter is taking the precautionary step of recalling all remaining heparin sodium injection and heparin flush products that are currently on the market. In addition to the previously recalled lots of heparin sodium injection 1000 units/mL 10mL and 30mL multi- dose vials, Baxter's recall will now include the remaining lots of those products and heparin sodium injection 5000 units/mL 10mL multi-dose vials, heparin sodium injection 10,000 units/mL 4mL multi-dose vials, heparin sodium injection 1000 USP un
'/>"/>

SOURCE Baxter International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
2. Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology
3. Baxter Named to Dow Jones Sustainability Index for Ninth Consecutive Year
4. Baxter and Novation Sign Multi-Year Contract Extension Valued at Over $200 Million for Medication Delivery Products
5. Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio
6. Baxter Kidney Patient Education Program Celebrates Tenth Anniversary
7. Baxter Receives 510(k) Clearance From FDA For V-Link With VitalShield, New Antimicrobial Intravascular Technology
8. Baxter Announces FDA Approval of GELFOAM(R) Plus Hemostasis Kit
9. Baxter International Fourth Quarter 2007 Financial Results Conference Call
10. Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/mL 10 and 30mL Multi-Dose Vials
11. Baxters Costa Rica Facility Recognized With Shingo Prize for Excellence in Manufacturing

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., NEW YORK, Dec. 2 Reportlinker...s available in its catalogue: ,, Drug Discover...& Opportunities ,, http://www.reportlinke...bal-Update-of-Market-Trends--Opportunities.html ,...oing element of every pharmaceutical company,s bus...
(Date:12/2/2009)... , CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Onc...") (TSX:ONC; NASDAQ: ONCY ) announced today that i...fering, the underwriters have exercised in full th...nal 637,500 units. Each unit is comprised of one c...rant, and was sold at a price of US$3.00 per unit....
(Date:12/2/2009)... , JERUSALEM, Israel, December 2 /PRNewswir...udy evaluating the preclinical (animal study) safe...mbines technology from Weill,Cornell Medical Colle... to,treat inherited anemias such as Cooley,s Anemi...f technologies to expand, ex vivo,populations of ...
(Date:12/2/2009)...UEBEC CITY, Dec. 2 /PRNewswire-FirstCall/ - AEtern...ompany"), a global biopharmaceutical company focus...ced that the U.S. Food and Drug Administration (FD...any,s PI3K/Akt pathway inhibitor compound, perifos...actory multiple myeloma. Keryx Biopharmaceuticals,...
Breaking Biology Technology:Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3
...rchers at The University of Texas at San Antonio (...iseases and The University of Texas Health Science... cell type believed to play a role in controlling ...tularensis, a respiratory pathogen and bioterrori...ngs will be released this week in a journal articl...
...fumes in subways, toxic gases in chemical spills, ...r and more efficient with a measurement technique ...er improve the technique,s sensitivity, scientists...effective ways of evaluating them. , Researchers a...fessor Dana Dlott, have devised a method to evalua...
...cer Center physicians today released results of re...o Agent Orange have greatly increased risks of pro... most aggressive form of the disease as compared t...ch appear online now and will be published in the ...e first to reliably link the herbicide with this f...
Other Biology Technology:UTSA/UTHSCSA publish results on bio-threat agent 2Killer pulses help characterize special surfaces 2Exposure to Agent Orange linked to prostate cancer in Vietnam veterans 2
(Date:12/2/2009)...lescents exposed to cigarette smoking scenes in mo...es, and this may be part of the acculturation proc...to new study findings. , "Our study supports an ...lights the global implementation of the World Heal...ntrol, which includes guidelines for countries to ...
(Date:12/2/2009)... Mountain forest,s woodland herb population has sh...erstories recover from logging, according to Purdu...n portions of the forest nearly 80 years ago, the ...orest floor was similar to that of undisturbed are...of forestry and natural resources, said that contr...
(Date:12/2/2009)...raduate students from Stevens Institute of Technol...ntest hosted by the International Society for Phar...est highlights the research conducted by the stude...ting in San Diego, Calif. , The winning poster, ...t Tensioning Device," was presented by Aaron Rella...
Breaking Biology News(10 mins):Watching movies featuring characters who smoke negatively influences Mexican-American teens 2Study finds logging effects vary based on a forest's history, climate 2Twelve Year Old Girl With Facial Paralysis Is Smiling Again After Cutting Edge Facial Plastic Surgery 48300 1Twelve Year Old Girl With Facial Paralysis Is Smiling Again After Cutting Edge Facial Plastic Surgery 48300 2Twelve Year Old Girl With Facial Paralysis Is Smiling Again After Cutting Edge Facial Plastic Surgery 48300 3ThermoGenesis Announces National Institute of Health Grant 4576 1ThermoGenesis Announces National Institute of Health Grant 4576 2ThermoGenesis Announces National Institute of Health Grant 4576 3ThermoGenesis Announces National Institute of Health Grant 4576 4Animal model for schizophrenia identifies a novel approach for treating cognitive impairments 48297 1Animal model for schizophrenia identifies a novel approach for treating cognitive impairments 48297 2
...t management efforts intended to assist migrations... consequences for fish populations. Juveniles that...ability to migrate back to their breeding grounds,...ons in the wild. , Transportation programs have ...e survival of fish that hatch in rivers but migrat...
...mber 25, 2008, the Obesity Institute at Children...any disciplines to share ideas, failures and succe...ervention strategies to fight childhood obesity, b... Through the Obesity Institute, Children,s Nationa...isciplinary approach that draws upon our experts f...
...re looking for bonefish from Miami down to the Mar...rom, and that is down slightly from the average of...ation among those who are counting, researchers sp...ol of Marine and Atmospheric Science held the sixt...ion with the conservation group Bonefish & Tarpon ...
Other Biology News:Transporting juvenile salmon hinders adult migration 2Transporting juvenile salmon hinders adult migration 3Children's National convenes first childhood obesity symposium 2Children's National convenes first childhood obesity symposium 3Children's National convenes first childhood obesity symposium 4Bonefish census reveals population holding steady 2
Goat Anti-PITPN Antibody, Unconjugated from Raybiotech, Inc.
ThermoTWISTER comfort from QUANTIFOIL Instruments
Mouse Anti-PDK1 Docking Motif, phospho (Ser / Thr) Monoclonal Antibody, Unconjugated, Clone 18A2 from Cell Signaling Technology
Rabbit Anti-Herstatin Polyclonal Antibody, Unconjugated from Abcam
Biology Products: